Stay updated on Expanded Access of Lifileucel in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Expanded Access of Lifileucel in Melanoma: Clinical Trial page.

Latest updates to the Expanded Access of Lifileucel in Melanoma: Clinical Trial page
- Check6 days agoChange DetectedThe page revision was updated to v3.5.4, replacing the previous v3.5.3, signaling an update to the page content.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe study’s listed locations were updated, including adding additional participating centers such as South Austin Medical Center, Vanderbilt University, SCRI Oncology Partners, and others, along with changes to the displayed total number of U.S. locations. The page also shows updated record dates (e.g., last update submitted/posted) accompanying the location changes.SummaryDifference3%

- Check34 days agoChange DetectedAdded Revision: v3.5.2; removed Revision: v3.5.0.SummaryDifference0.0%

- Check63 days agoChange DetectedA new page revision, v3.5.0, has been added and the previous revision, v3.4.3, removed.SummaryDifference0.0%

- Check70 days agoChange DetectedRevision: v3.4.3 was added. Revision: v3.4.2 was removed.SummaryDifference0.0%

- Check98 days agoChange DetectedA new Revision: v3.4.2 entry was added; the previous funding notice and Revision: v3.4.1 were removed.SummaryDifference0.4%

Stay in the know with updates to Expanded Access of Lifileucel in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Expanded Access of Lifileucel in Melanoma: Clinical Trial page.